GSK plc (GSK)

Every figure this model derived for GSK, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,348,000,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 3,439,000,000 CashAndCashEquivalents 2025-12-31
current assets 17,510,000,000 CurrentAssets 2025-12-31
current liabilities 21,391,000,000 CurrentLiabilities 2025-12-31
equity 16,377,000,000 EquityAttributableToOwnersOfParent 2025-12-31
interest expense 701,000,000 FinanceCosts 2025-12-31
ocf 7,741,000,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 32,667,000,000 RevenueFromSaleOfGoods 2025-12-31
sbc 390,000,000 ExpenseFromSharebasedPaymentTransactionsWithEmployees 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up GSK on one particular measure came for.

RatioValue
cash operating margin32.56
current ratio0.82
current ratio reported0.82
ev ebit21.99
ev owner earnings29.06
ev sales5.34
fcf margin19.57
interest cover11.32
net debt ebitda1.45
operating margin24.28
owner earnings margin18.38
revenue growth4.11
revenue growth per share4.11
roic20.06
rule of 4028.4
sbc pct revenue1.19

What to be careful about

What this model itself distrusts about GSK's figures. Written by the derivation as it ran, not added afterwards.